Sravan K. Jonnalagadda

Monocarboxylate Transporter 1 Inhibitors as Potential Anticancer Agents

Shirisha Gurrapu, Sravan K. Jonnalagadda, Mohammad A. Alam et al. · ACS Medicinal Chemistry Letters · 2015 · 46 citations · Full text

Monocarboxylate Transporter 1, Mct1 Inhibitory Activity, Pharmacotherapy +17

Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents

Shirisha Gurrapu, Sravan K. Jonnalagadda, Mohammad A. Alam et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 39 citations · Full text

Medicinal Chemistry, Medicine, Monocarboxylate Transporter 1 +9

Novel N,N-dialkyl cyanocinnamic acids as monocarboxylate transporter 1 and 4 inhibitors

Shirisha Jonnalagadda, Sravan K. Jonnalagadda, Conor T. Ronayne et al. · Oncotarget · 2019 · 34 citations · Full text

Synthesis and evaluation of functionalized benzoboroxoles as potential anti-tuberculosis agents

Mohammad A. Alam, Kriti Arora, Shirisha Gurrapu et al. · Tetrahedron · 2016 · 29 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Functionalized Benzoboroxoles +8

Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment

Grady L. Nelson, Conor T. Ronayne, Lucas N. Solano et al. · Scientific Reports · 2019 · 20 citations · Full text

Chemoprevention Strategy, Chemical Derivative, Pharmaceutical Chemistry +16